| |
 |
|
Class Information
Number: 424/93.21
Name: Drug, bio-affecting and body treating compositions > Whole live micro-organism, cell, or virus containing > Genetically modified micro-organism, cell, or virus (e.g., transformed, fused, hybrid, etc.) > Eukaryotic cell
Description: Subject matter involving an eukaryotic cell, such as an animal cell, plant cell, fungus, protozoa, or higher algae which has been genetically modified.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7612046 |
Method for treating kidney disorders |
Nov. 3, 2009 |
| 7604798 |
Methods and compositions for importing nucleic acids into cell nuclei |
Oct. 20, 2009 |
| 7601343 |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
Oct. 13, 2009 |
| 7601344 |
Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells |
Oct. 13, 2009 |
| 7601345 |
Lentivirus vectors for gene transfer to alveolar epithelial cells |
Oct. 13, 2009 |
| 7595431 |
Mouse models of human prostate cancer |
Sep. 29, 2009 |
| 7592321 |
Methods of treating lysosomal storage related diseases by gene therapy |
Sep. 22, 2009 |
| 7592176 |
Method of forming mesenchymal stem cells from embryonic stem cells |
Sep. 22, 2009 |
| 7589071 |
Large capacity viral amplicon using a minimal orilyt from human cytomegalovirus |
Sep. 15, 2009 |
| 7585498 |
Regulation of adenovirus DNA packaging by IPTG |
Sep. 8, 2009 |
| 7585675 |
Inhibition of HIV and SHIV replication with antisense interleukin-4 |
Sep. 8, 2009 |
| 7582292 |
Adipose tissue derived stromal cells for the treatment of neurological disorders |
Sep. 1, 2009 |
| 7579330 |
Methods of treating various cancers using melanoma differentiation associated protein-7 |
Aug. 25, 2009 |
| 7575921 |
Spore-like cells and uses thereof |
Aug. 18, 2009 |
| 7575743 |
Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells |
Aug. 18, 2009 |
| 7569220 |
Compositions and methods for non-targeted activation of endogenous genes |
Aug. 4, 2009 |
| 7569221 |
Compositions and methods for identifying agents that alter expression of survivin |
Aug. 4, 2009 |
| 7563278 |
Drug-eluting intravascular prostheses and methods of use |
Jul. 21, 2009 |
| 7563776 |
Compositions comprising fusion polypeptides HIV-Nef and NGF, and methods of using the same |
Jul. 21, 2009 |
| 7550138 |
Plasmodium mutant and vaccines including the mutant |
Jun. 23, 2009 |
| 7541446 |
Tet repressor-based transcriptional regulatory proteins |
Jun. 2, 2009 |
| 7538097 |
Inhibition of antigen presentation with poorly catabolized polymers |
May. 26, 2009 |
| 7534424 |
Method of enhancing delivery of a therapeutic nucleic acid |
May. 19, 2009 |
| 7534613 |
Methods of treating parkinson's disease using viral vectors |
May. 19, 2009 |
| 7531167 |
Herpes simplex virus vector |
May. 12, 2009 |
| 7524492 |
Insulin related transcription factor and uses thereof |
Apr. 28, 2009 |
| 7524493 |
Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension |
Apr. 28, 2009 |
| 7517669 |
Gene regulation therapy involving ferritin |
Apr. 14, 2009 |
| 7514537 |
Chimeric immunoreceptor useful in treating human gliomas |
Apr. 7, 2009 |
| 7504099 |
Methods of inducing or enhancing connective tissue repair |
Mar. 17, 2009 |
| 7504100 |
Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
Mar. 17, 2009 |
| 7504560 |
Vaccines expressed in plants |
Mar. 17, 2009 |
| 7494644 |
Methods and compositions for correction of cardiac conduction disturbances |
Feb. 24, 2009 |
| 7491385 |
Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
Feb. 17, 2009 |
| 7488719 |
Wound and cutaneous injury healing with a nucleic acid encoding perlecan |
Feb. 10, 2009 |
| 7473556 |
Method for producing dendritic cells |
Jan. 6, 2009 |
| 7473418 |
Pan cancer oncolytic vectors and methods of use thereof |
Jan. 6, 2009 |
| 7470675 |
Methods for treating cancer using interferon-.omega.-expressing polynucleotides |
Dec. 30, 2008 |
| 7465442 |
Reduction of dermal scarring |
Dec. 16, 2008 |
| 7465583 |
Duplexed parvovirus vectors |
Dec. 16, 2008 |
| 7459602 |
Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
Dec. 2, 2008 |
| 7452530 |
Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
Nov. 18, 2008 |
| 7452529 |
Treatment of muscular dystrophy with cord blood cells |
Nov. 18, 2008 |
| 7449179 |
Vectors for conditional gene inactivation |
Nov. 11, 2008 |
| 7449565 |
Chimeric tumor suppressor gene and protein |
Nov. 11, 2008 |
| 7445775 |
Yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
Nov. 4, 2008 |
| 7442377 |
Protective antigen of epstein barr virus |
Oct. 28, 2008 |
| 7439233 |
Vaccine for house dust mite allergen using naked DNA |
Oct. 21, 2008 |
| 7435872 |
Role of p62 in aging-related disease |
Oct. 14, 2008 |
| 7431922 |
Bioadhesive directed somatic cell therapy |
Oct. 7, 2008 |
|
|
|
